Equity Compensation Plan - Summary of the Company's Non-Vested Stock Option Activity and Related Information (Detail) - $ / shares |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Equity Compensation Plan Arrangement [Abstract] | |||
| Beginning Balance, Option shares | 445,375 | 631,250 | 0 |
| Granted, Option shares | 611,503 | 111,000 | 631,250 |
| Exercised, Option shares | (346,875) | (296,875) | |
| Ending Balance, Option shares | 710,003 | 445,375 | 631,250 |
| Exercisable, Option shares | 43,000 | 18,750 | 0 |
| Beginning Balance, Weighted- Average Exercise Price | $ 2.1 | $ 1.6 | $ 0 |
| Granted, Weighted- Average Exercise Price | 3.11 | 3.6 | 1.6 |
| Exercised, Weighted- Average Exercise Price | 1.89 | 1.6 | |
| Ending Balance, Weighted- Average Exercise Price | 3.07 | 2.1 | 1.6 |
| Exercisable, Weighted- Average Exercise Price | $ 1.86 | $ 1.6 | $ 0 |
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award options non vested end of exercisable number of shares. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award options nonvested exercisable weighted average exercise price. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which option holders acquired shares when converting their stock options into shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of non-vested options outstanding. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Weighted average grant-date fair value of non-vested options outstanding. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of share options (or share units) exercised during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|